Omega-3 Fatty Acid-derived Resolvins and Protectins in Inflammation Resolution and Leukocyte Functions: Targeting Novel Lipid Mediator Pathways in Mitigation of Acute Kidney Injury

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2013 Feb 7

PMID 23386851

Citations 35

Authors

Song Hong

Yan Lu

Affiliations

Soon will be listed here.

Abstract

Inflammation, in conjunction with leukocytes, plays a key role in most acute kidney injury (AKI). Non-resolving renal inflammation leads to chronic fibrosis and renal failure. Resolvin D series (RvDs) and E series (RvEs), protectins, and maresins (MaRs) are endogenous omega-3 fatty acid-derived lipid mediators (LMs) that potently promote inflammation resolution by shortening neutrophil life span and promoting macrophage (Mf) non-phelogistic phagocytosis of apoptotic cells and the subsequent exit of Mfs from inflammatory tissue. 14S,21R-dihydroxy docosahexaenoic acid (14S,21R-diHDHA), a Mf-produced autacrine, reprograms Mfs to rescue vascular endothelia. RvD1, RvE1, or 14S,21R-diHDHA also switches Mfs to the phenotype that produces pro-resolving interleukin-10. RvDs or protectin/neuroprotectin D1 (PD1/NPD1) inhibits neutrophil infiltration into injured kidneys, blocks toll-like receptor -mediated inflammatory activation of Mfs and mitigates renal functions. RvDs also repress renal interstitial fibrosis, and PD1 promotes renoprotective heme-oxygenase-1 expression. These findings provide novel approaches for targeting inflammation resolution and LMs or modulation of LM-associated pathways for developing better clinical treatments for AKI.

Citing Articles

Protective effect of long-chain polyunsaturated fatty acids on hepatorenal syndrome in rats.

Duailibe J, Viau C, Saffi J, Fernandes S, Porawski M World J Nephrol. 2024; 13(3):95627.

PMID: 39351184 PMC: 11439093. DOI: 10.5527/wjn.v13.i3.95627.

MAFB in Macrophages Regulates Prostaglandin E2-Mediated Lipid Mediator Class Switch through ALOX15 in Ischemic Acute Kidney Injury.

Kanai M, Nishino T, Daassi D, Kimura A, Liao C, Shahri Z J Immunol. 2024; 213(8):1212-1224.

PMID: 39230290 PMC: 11457724. DOI: 10.4049/jimmunol.2300844.

Highlighting the Effect of Pro-inflammatory Mediators in the Pathogenesis of Periodontal Diseases and Alzheimer's Disease.

Hashim N, Babiker R, Mohammed R, Chaitanya N, Rahman M, Gismalla B J Pharm Bioallied Sci. 2024; 16(Suppl 2):S1120-S1128.

PMID: 38882732 PMC: 11174192. DOI: 10.4103/jpbs.jpbs_1120_23.

Promising Anti-Inflammatory Tools: Biomedical Efficacy of Lipoxins and Their Synthetic Pathways.

Chi J, Cheng J, Wang S, Li C, Chen M Int J Mol Sci. 2023; 24(17).

PMID: 37686088 PMC: 10487465. DOI: 10.3390/ijms241713282.

Polymorphisms in Lymphotoxin-Alpha as the "Missing Link" in Prognosticating Favourable Response to Omega-3 Supplementation for Dry Eye Disease: A Narrative Review.

Paik B, Tong L Int J Mol Sci. 2023; 24(4).

PMID: 36835647 PMC: 9965360. DOI: 10.3390/ijms24044236.

References

Alikhan M, Jones C, Williams T, Beckhouse A, Fletcher A, Kett M . Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am J Pathol. 2011; 179(3):1243-56. PMC: 3157188. DOI: 10.1016/j.ajpath.2011.05.037. View

Tian H, Lu Y, Shah S, Hong S . Autacoid 14S,21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions. Am J Pathol. 2011; 179(4):1780-91. PMC: 3181353. DOI: 10.1016/j.ajpath.2011.06.026. View

McMahon B, Stenson C, McPhillips F, Fanning A, Brady H, Godson C . Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J Biol Chem. 2000; 275(36):27566-75. DOI: 10.1074/jbc.M001015200. View

Mukherjee P, Marcheselli V, Serhan C, Bazan N . Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A. 2004; 101(22):8491-6. PMC: 420421. DOI: 10.1073/pnas.0402531101. View

Schwab J, Chiang N, Arita M, Serhan C . Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007; 447(7146):869-74. PMC: 2757086. DOI: 10.1038/nature05877. View

Kieran N, Maderna P, Godson C . Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. Kidney Int. 2004; 65(4):1145-54. DOI: 10.1111/j.1523-1755.2004.00487.x. View

Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S . Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005; 201(5):713-22. PMC: 2212834. DOI: 10.1084/jem.20042031. View

Schif-Zuck S, Gross N, Assi S, Rostoker R, Serhan C, Ariel A . Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol. 2011; 41(2):366-79. PMC: 3082320. DOI: 10.1002/eji.201040801. View

Morgera S, Kraft A, Siebert G, Luft F, Neumayer H . Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis. 2002; 40(2):275-9. DOI: 10.1053/ajkd.2002.34505. View

10.

El Kebir D, Gjorstrup P, Filep J . Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc Natl Acad Sci U S A. 2012; 109(37):14983-8. PMC: 3443132. DOI: 10.1073/pnas.1206641109. View

11.

Maddox J, Hachicha M, Takano T, Petasis N, Fokin V, Serhan C . Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem. 1997; 272(11):6972-8. DOI: 10.1074/jbc.272.11.6972. View

12.

Hong S, Porter T, Lu Y, Oh S, Pillai P, Serhan C . Resolvin E1 metabolome in local inactivation during inflammation-resolution. J Immunol. 2008; 180(5):3512-9. DOI: 10.4049/jimmunol.180.5.3512. View

13.

Kucharzik T, Gewirtz A, Merlin D, Madara J, Williams I . Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium. Am J Physiol Cell Physiol. 2002; 284(4):C888-96. DOI: 10.1152/ajpcell.00507.2001. View

14.

Maderna P, Godson C . Lipoxins: resolutionary road. Br J Pharmacol. 2009; 158(4):947-59. PMC: 2785518. DOI: 10.1111/j.1476-5381.2009.00386.x. View

15.

Arita M, Oh S, Chonan T, Hong S, Elangovan S, Sun Y . Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J Biol Chem. 2006; 281(32):22847-54. DOI: 10.1074/jbc.M603766200. View

16.

Foell D, Wittkowski H, Vogl T, Roth J . S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2006; 81(1):28-37. DOI: 10.1189/jlb.0306170. View

17.

Serhan C, Petasis N . Resolvins and protectins in inflammation resolution. Chem Rev. 2011; 111(10):5922-43. PMC: 3192290. DOI: 10.1021/cr100396c. View

18.

Borgeson E, Godson C . Molecular circuits of resolution in renal disease. ScientificWorldJournal. 2010; 10:1370-85. PMC: 5763933. DOI: 10.1100/tsw.2010.120. View

19.

Vernon M, Mylonas K, Hughes J . Macrophages and renal fibrosis. Semin Nephrol. 2010; 30(3):302-17. DOI: 10.1016/j.semnephrol.2010.03.004. View

20.

Fiore S, Maddox J, Perez H, Serhan C . Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med. 1994; 180(1):253-60. PMC: 2191537. DOI: 10.1084/jem.180.1.253. View